We are live on ! Find out more
GW & Wade

GW & Wade Portfolio holdings

AUM $3.08B Turnover 13.09%
1-Year Est. Return 18.99%
This Fund
S&P 500
This Quarter Est. Return
+3.95%
1 Year Est. Return
+18.99%
3 Year Est. Return
+32.19%
5 Year Est. Return
+95.75%
10 Year Est. Return
+162.41%
AUM
$583M
AUM Growth
+$70.5M
Cap. Flow
+$51.4M
Cap. Flow %
8.81%
Top 10 Hldgs %
36.17%
Holding
250
New
35
Increased
100
Reduced
52
Closed
16
Avg Time Held
1.4 years
Top 10 Avg Time Held
1.4 years
Top 20 Avg Time Held
1.7 years

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$6.06M
2
MET icon
MetLife
MET
+$5.53M
3
BA icon
Boeing
BA
+$4.61M
4
EXR icon
Extra Space Storage
EXR
+$4.19M
5
ORCL icon
Oracle
ORCL
+$2.67M

Top Sells

Rank Stock Value
1
CLX icon
Clorox
CLX
+$6.06M
2
ED icon
Consolidated Edison
ED
+$4.43M
3
SYY icon
Sysco
SYY
+$4.28M
4
UL icon
Unilever
UL
+$4.01M
5
VB icon
Vanguard Morningstar Small-Cap ETF
VB
+$1.16M

Sector Composition

Rank Sector Weight
1 Miscellaneous 25.99%
2 Energy 16.96%
3 Industrials 11.08%
4 Technology 9.6%
5 Financials 8.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
EMC icon
126
DELISTED
EMC CORPORATION
EMC
$625K 0.11%
22,999
+6,234
+37% +$168K
2015 Q2
4 quarters
VWO icon
127
Vanguard FTSE Emerging Markets ETF
VWO
$124B
$608K 0.1%
17,250
-15,376
-47% -$525K
2014 Q4
6 quarters
GD icon
128
General Dynamics
GD
$90.8B
$604K 0.1%
4,341
+13
+0.3% +$1.81K
2015 Q1
5 quarters
SE icon
129
DELISTED
Spectra Energy Corp Wi
SE
$588K 0.1%
16,064
– –
2015 Q1
5 quarters
VTR icon
130
Ventas
VTR
$43.8B
$582K 0.1%
7,994
+1
+0% +$66
2015 Q1
5 quarters
ABT icon
131
Abbott
ABT
$181B
$571K 0.1%
14,520
+1,174
+9% +$46.7K
2015 Q1
5 quarters
ABBV icon
132
AbbVie
ABBV
$506B
$563K 0.1%
9,097
-40
-0.4% -$2.44K
2015 Q1
5 quarters
ACN icon
133
Accenture
ACN
$138B
$563K 0.1%
4,972
+4
+0.1% +$464
2015 Q1
5 quarters
VTI icon
134
Vanguard Morningstar Total Stock Market ETF
VTI
$696B
$563K 0.1%
5,250
-98
-2% -$10.4K
2015 Q1
5 quarters
DFT
135
DELISTED
DuPont Fabros Technology Inc.
DFT
$561K 0.1%
11,805
– –
2015 Q1
5 quarters
LLY icon
136
Eli Lilly
LLY
$1.12T
$540K 0.09%
6,855
-315
-4% -$23.7K
2014 Q4
6 quarters
EPR icon
137
EPR Properties
EPR
$4.23B
$530K 0.09%
6,565
– –
2015 Q1
5 quarters
CME icon
138
CME Group
CME
$104B
$516K 0.09%
5,301
– –
2015 Q1
5 quarters
BSX icon
139
Boston Scientific
BSX
$63.4B
$514K 0.09%
21,977
– –
2015 Q1
5 quarters
V icon
140
Visa
V
$752B
$506K 0.09%
6,817
+421
+7% +$33K
2015 Q2
4 quarters
HD icon
141
Home Depot
HD
$305B
$499K 0.09%
3,906
-337
-8% -$44.6K
2015 Q1
5 quarters
DWM icon
142
WisdomTree International Equity Fund
DWM
$650M
$474K 0.08%
10,588
– –
2013 Q4
10 quarters
M icon
143
Macy's
M
$6.27B
$471K 0.08%
14,008
+623
+5% +$22.3K
2014 Q4
6 quarters
MDT icon
144
Medtronic
MDT
$122B
$466K 0.08%
5,365
-1,424
-21% -$115K
2015 Q1
5 quarters
WY icon
145
Weyerhaeuser
WY
$14.1B
$466K 0.08%
15,657
– –
2015 Q1
5 quarters
DHS icon
146
WisdomTree US High Dividend Fund
DHS
$1.59B
$456K 0.08%
6,838
-1,070
-14% -$68.5K
2014 Q4
6 quarters
TFCFA
147
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$452K 0.08%
16,709
+1
+0% +$29
2015 Q1
5 quarters
CRM icon
148
Salesforce
CRM
$201B
$428K 0.07%
5,387
+300
+6% +$23.5K
2016 Q1
1 quarter
WMT icon
149
Walmart Inc
WMT
$939B
$425K 0.07%
17,445
+300
+2% +$6.94K
2015 Q2
4 quarters
WTW icon
150
Willis Towers Watson
WTW
$28.9B
$424K 0.07%
+3,410
New +$421K
2016 Q2
0 quarters

Similar funds

GW & Wade's Q2 2016 Portfolio in Review

As of Q2 2016, GW & Wade held 250 positions worth $583M, up 14% from $512M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

GW & Wade deployed $51.4M of net new capital in Q2 2016, opening 35 new positions and adding to 100 existing holdings. Its largest new stake was MetLife: 141,821 shares worth $5.04M.

By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 30% a quarter earlier, followed by Energy and Industrials.

On the sell side, the largest reduction was Clorox, an estimated $6.06M trimmed.

  • GW & Wade's largest Q2 2016 buy was MetLife: 141,821 shares worth $5.04M.
  • GW & Wade added most to Amgen in Q2 2016, an estimated $6.06M increase.
  • GW & Wade's biggest Q2 2016 reduction was Clorox, cutting an estimated $6.06M.
  • GW & Wade fully exited Unilever in Q2 2016, selling an estimated $4.01M.
  • GW & Wade's ten largest holdings make up 36% of its $583M portfolio in Q2 2016.
  • GW & Wade opened 35 new positions and closed 16 in Q2 2016.
  • GW & Wade's portfolio value rose 14% quarter-over-quarter to $583M.

Based on GW & Wade's 13F filing for Q2 2016, filed 5 Aug 2016.